17-Oct-2006 - Pfizer CentreSource has decided to outsource the manufacture of some of its active pharmaceutical ingredients (API) to two Asian contract manufacturers and intends to work with the Food and Drug Administration's (FDA) during the process.
26-Mar-2007 - Active pharmaceutical ingredient (API) specialist ScinoPharm has been assigned a drug master file (DMF) number for its anti-cancer ingredient docetaxel, the first such designation for the API in the US.
02-Feb-2007 - Pfizer's latest cutbacks will provide a new outsourcing opportunity for contract manufacturing organisations (CMOs) in low-cost destinations as the drug giant announces plans to double its amount of drug production outsourcing.
15-Nov-2006 - International drug firms are increasingly turning to Taiwan for the low-cost made-to-order processing of active pharmaceutical ingredients (APIs), according to the Taiwan External Trade Development Council (TAITRA).
25-Jan-2006 - Taiwanese generic and contract manufacturer ScinoPharm has seen its sales almost double for the last three years, from $5 m in 2002 to $31m in 2005, fuelled by its booming active pharmaceutical ingredient (API) business.